Literature DB >> 31523152

The Sole Initial Imaging Finding in Creutzfeldt-Jacob Disease: Focal FDG-PET Hypometabolism.

Ahmet Kasım Kiliç1, Bahar Kaymakamzade2, Esen Saka1, Ersin Tan1.   

Abstract

Laboratory studies such as electroencephalography, cerebrospinal fluid examination and diffusion-weighted magnetic resonance imaging (DWI-MRI) are valuable in the diagnosis of Creutzfeldt-Jacob disease (CJD),. However, these laboratory studies may not show the characteristic findings in the very early stage of the disease. Here, we present a case of CJD who had atypical neurologic presentation initially and had only a focal parietal 2-(18F) fluorodeoxyglucose (FDG) positron emission tomography (PET) hypometabolism as the sole imaging abnormality at the beginning. The patient progressed rapidly, and showed typical neurological findings for CJD. The brain MRI was performed two weeks after the FDG-PET study, finally demonstrated increased signal intensity in DWI in caudat nucleus, putamen, and cerebral cortex, especially on left parietal region. Imaging methods demonstrating functional alterations in the brain should be obtained in the early period in patients with normal MRI suspected having CJD. Repeating DWI could also be an effective diagnostic approach.

Entities:  

Keywords:  Creutzfeldt-Jacob; PET; magnetic resonance imaging; positron emission tomography; prion

Year:  2018        PMID: 31523152      PMCID: PMC6732803          DOI: 10.5152/npa.2017.19471

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  2 in total

1.  18FDG PET-CT in sporadic Creutzfeldt-Jakob disease, correlated with MRI and histology.

Authors:  Nicholas C D Morley; Monika Hofer; Philip Wilkinson; Kevin M Bradley
Journal:  World J Nucl Med       Date:  2021-10-12

2.  18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom.

Authors:  Songhan Tang; Xiaofeng Dou; Ying Zhang
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.